CbdMD, Inc. Provides Preliminary Earnings Guidance for the Fourth Quarter and Year Ended September 30, 2020
October 14, 2020 at 06:30 pm IST
Share
cbdMD, Inc. provided preliminary earnings guidance for the fourth quarter and year ended September 30, 2020. The company net sales revenue for the fourth quarter of fiscal 2020 is expected to range between $11.5 and $11.7 million compared to $9.54 million in the fourth quarter of fiscal 2019.
The company net sales revenue for fiscal 2020 is expected to range between $41.7 and $41.8 compared to $23.7 million in fiscal 2019.
cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids.Its Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Its cbdMD Botanicals brand of beauty and skincare products features facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care stock-keeping units (SKU). cbdMD, Paw CBD and cbdMD Botanicals products are distributed through its e-commerce websites, third party ecommerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers. Its products are sold through www.cbdmd.com, www.pawcbd.com, and cbdmdbotanicals.com Websites.